NCT07577427

Brief Summary

PATIENTS AFFECTED BY ADRENAL GLAND DISEASE WITH SURGICAL INDICATION OF ROBOTIC OR LAPAROSCOPIC ADRENALECTOMY

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
7mo left

Started May 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
May 2026Dec 2026

First Submitted

Initial submission to the registry

May 3, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

May 3, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 11, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 11, 2026

Status Verified

May 1, 2026

Enrollment Period

8 months

First QC Date

May 3, 2026

Last Update Submit

May 3, 2026

Conditions

Adrenal Gland Disease

Outcome Measures

Primary Outcomes (1)

  • POSTOPERATIVE COMPLICATIONS

    CLAVIEN-DINDO SCORE

    FROM ENROLLMENT TO THE END OF TREATMENT AT 5 YEARS

Interventions

Surgery with and without the aid of Indocyanine Green (ICG)PROCEDURE

NO DIFFERENCES

Also known as: ADRENALECTOMY

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

PATIENTS AFFECTED BY ADRENAL GLAND DISEASE WHIT INDICATIONS TO ADRENALECTOMY

You may qualify if:

  • ADRENAL GLAND DISEASE

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Policlinico Umberto I

Roma, Italy

Location

MeSH Terms

Conditions

Adrenal Gland Diseases

Interventions

Surgical Procedures, OperativeAdrenalectomy

Condition Hierarchy (Ancestors)

Endocrine System Diseases

Intervention Hierarchy (Ancestors)

Endocrine Surgical Procedures

Central Study Contacts

PAOLO SAPIENZA, PROFESSOR

CONTACT

00390649972157paolo.sapienza@uniroma1.it

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 3, 2026

First Posted

May 11, 2026

Study Start

May 3, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 11, 2026

Record last verified: 2026-05

Locations

IT(1)